Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV?

Kretzschmar M, Zhang W, Mikolajczyk RT, Wang L, Sun X, Krämer A, Lv F (2008)
BMC Infectious Diseases 8(1): 108.

Download
OA
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Volltext vorhanden für diesen Nachweis
Autor
; ; ; ; ; ;
Abstract / Bemerkung
Background: Drug use and in particular injecting drug use has been at the forefront of the explosive spread of HIV in general populations in many countries in Asia. There is concern that also in China increased HIV incidence in drug users might spark off a generalized epidemic in the wider population. Close monitoring of HIV incidence and risk factors in drug users is therefore important to be able to target interventions effectively. Second generation surveillance was launched to assess HIV prevalence and risk behaviours jointly with the purpose of describing trends and predicting future developments. To assess whether these goals were fulfilled among drug users in China we provide an analysis of risk factors for HIV infection and of regional differences in HIV prevalence. Methods: We analysed data collected in 2005 in 21 drug user second generation surveillance sentinel sites from 14 provinces in China. We used random effects logistic regression to test for risk factors for HIV infection and regional differences. Results: The overall HIV-1 antibody prevalence was 5.4% (279/5128); 4.9% among injecting drug users (IDU) not sharing needles and 3.7% among non-injecting drug users. We found substantial heterogeneity among the surveillance sites with prevalence rates ranging between 0% and 54%. HIV status was strongly affected by the regional prevalence of HIV. Risk behaviours were highly prevalent in regions where HIV prevalence is still low. The distribution of duration of drug use in different sites indicated different stages of the drug use epidemics. Conclusion: ]Regional differences in HIV prevalence in China reflect different stages of the drug use and HIV epidemics rather than differences in risk behaviours. Therefore, outbreaks of HIV among drug users in regions where prevalence is still low can be expected in the future. However, methodological limitations of surveillance embedded into routine systems limit the usability of existing data. More standardized approaches to data collection in secondary generation HIV surveillance are necessary to better understand regional differences in risk behaviour and prevalence and to design targeted intervention for those regions at risk of experiencing outbreaks.
Erscheinungsjahr
Zeitschriftentitel
BMC Infectious Diseases
Band
8
Ausgabe
1
Seite(n)
108
ISSN
PUB-ID

Zitieren

Kretzschmar M, Zhang W, Mikolajczyk RT, et al. Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infectious Diseases. 2008;8(1):108.
Kretzschmar, M., Zhang, W., Mikolajczyk, R. T., Wang, L., Sun, X., Krämer, A., & Lv, F. (2008). Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infectious Diseases, 8(1), 108. doi:10.1186/1471-2334-8-108
Kretzschmar, M., Zhang, W., Mikolajczyk, R. T., Wang, L., Sun, X., Krämer, A., and Lv, F. (2008). Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infectious Diseases 8, 108.
Kretzschmar, M., et al., 2008. Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infectious Diseases, 8(1), p 108.
M. Kretzschmar, et al., “Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV?”, BMC Infectious Diseases, vol. 8, 2008, pp. 108.
Kretzschmar, M., Zhang, W., Mikolajczyk, R.T., Wang, L., Sun, X., Krämer, A., Lv, F.: Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infectious Diseases. 8, 108 (2008).
Kretzschmar, Mirjam, Zhang, Weidong, Mikolajczyk, Rafael T., Wang, Lan, Sun, Xinhua, Krämer, Alexander, and Lv, Fan. “Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV?”. BMC Infectious Diseases 8.1 (2008): 108.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
This Item is protected by copyright and/or related rights. [...]
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
1970-01-01T00:00:00Z

14 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Sex work in geographic perspective: a multi-disciplinary approach to mapping and understanding female sex work venues in Southwest China.
Lorway R, Khan S, Chevrier C, Huynh A, Zhang J, Ma X, Blanchard J, Yu N., Glob Public Health 12(5), 2017
PMID: 26790097
Assessment of Different Intervention Models of Male Circumcision and Their Preliminary Effectiveness in Reducing HIV Incidence Among Drug Users in Western China.
Huang J, Jiang J, Yang X, Liang B, Qin B, Upur H, Zhong C, Wang Q, Wang Q, Ruan Y, Deng W, Xie P, Liao Y, Xu N, Zou Y, Wei F, Ye L, Liang H., AIDS Res Hum Retroviruses 32(10-11), 2016
PMID: 27400784
HIV epidemic among drug users in China: 1995-2011.
Wang L, Guo W, Li D, Ding Z, McGoogan JM, Wang N, Wu Z, Wang L, China National HIV/AIDS Surveillance Program., Addiction 110 Suppl 1(), 2015
PMID: 25533861
Geographical variations in risk factors associated with HIV infection among drug users in a prefecture in Southwest China.
Zhou YB, Wang QX, Liang S, Gong YH, Yang MX, Chen Y, Nie SJ, Nan L, Yang AH, Liao Q, Yang Y, Song XX, Jiang QW., Infect Dis Poverty 4(), 2015
PMID: 26329887
HIV-, HCV-, and co-infections and associated risk factors among drug users in southwestern China: a township-level ecological study incorporating spatial regression.
Zhou YB, Wang QX, Liang S, Gong YH, Yang MX, Nie SJ, Nan L, Yang AH, Liao Q, Yang Y, Song XX, Jiang QW., PLoS One 9(3), 2014
PMID: 24687006
Prevalence and correlates of sexual risk behaviors among drug users in western China: implications for HIV transmission.
Huang J, Jiang J, Li JZ, Yang X, Deng W, Abdullah AS, Qin B, Upur H, Zhong C, Wang Q, Wang Q, Ruan Y, Zou Y, Ye L, Xie P, Wei F, Xu N, Wei B, Liang H., AIDS Res Hum Retroviruses 29(4), 2013
PMID: 23210514
Factors associated with acceptability of circumcision among male drug users in western China: a cross-sectional study.
Huang J, Jiang J, Abdullah AS, Yang X, Wei B, Deng W, Qin B, Upur H, Zhong C, Wang Q, Wang Q, Ruan Y, Zou Y, Ye L, Xie P, Wei F, Xu N, Liang H., Int J STD AIDS 24(7), 2013
PMID: 23970769
Describing the Chinese HIV surveillance system and the influences of political structures and social stigma.
Zhang L, Chow EP, Zhang J, Jing J, Wilson DP., Open AIDS J 6(), 2012
PMID: 23049665
Lymphoepithelial cyst of the parotid gland: its possible histopathogenesis based on clinicopathologic analysis of 64 cases.
Wu L, Cheng J, Maruyama S, Yamazaki M, Tsuneki M, Lu Y, He Z, Zheng Y, Zhou Z, Saku T., Hum Pathol 40(5), 2009
PMID: 19157503

33 References

Daten bereitgestellt von Europe PubMed Central.

Expansion of HIV/AIDS in China: lessons from Yunnan Province.
Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH., Soc Sci Med 64(3), 2006
PMID: 17107739
China and HIV - a window of opportunity.
Gill B, Okie S., N. Engl. J. Med. 356(18), 2007
PMID: 17476005

Ministry PRC, Organisation WH., 2006
Drug use and HIV/AIDS in China.
Liu Z, Lian Z, Zhao C., Drug Alcohol Rev 25(2), 2006
PMID: 16627308
HIV/AIDS prevalence and behaviour in drug users and pregnant women in Kashgar Prefecture: case report.
Mingjian N, Wheeler KM, Cheng J, Yonghai D, Chen W, Fitzwarryne C, Wang J., Harm Reduct J 3(), 2006
PMID: 16476164
Community-based survey of HIV transmission modes among intravenous drug users in Sichuan, China.
Ruan Y, Chen K, Hong K, He Y, Liu S, Zhou F, Qin G, Chen J, Xing H, Shao Y., Sex Transm Dis 31(10), 2004
PMID: 15389002
The development of HIV/AIDS surveillance in China.
Sun X, Wang N, Li D, Zheng X, Qu S, Wang L, Lu F, Poundstone K, Wang L., AIDS 21 Suppl 8(), 2007
PMID: 18172389
Heterosexual transmission of HIV in China: a systematic review of behavioral studies in the past two decades.
Yang H, Li X, Stanton B, Liu H, Liu H, Wang N, Fang X, Lin D, Chen X., Sex Transm Dis 32(5), 2005
PMID: 15849527
Second-generation HIV surveillance: better data for decision-making.
Rehle T, Lazzari S, Dallabetta G, Asamoah-Odei E., Bull. World Health Organ. 82(2), 2004
PMID: 15042234
Injection drug use and HIV/AIDS transmission in China.
Chu TX, Levy JA., Cell Res. 15(11-12), 2005
PMID: 16354561
Drug problem in southeast and southwest Asia.
Kulsudjarit K., Ann. N. Y. Acad. Sci. 1025(), 2004
PMID: 15542748
Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications.
Qian HZ, Schumacher JE, Chen HT, Ruan YH., Harm Reduct J 3(), 2006
PMID: 16451717
Prevalence and correlates of HIV risk behaviors among drug users in China.
Yang X, Latkin C, Celentano D, Luo H., AIDS Behav 10(1), 2006
PMID: 16323036
Clustering of syringe sharing and unprotected sex risk behaviors in male injecting drug users in China.
Lau JT, Cheng F, Tsui HY, Zhang Y, Zhang J, Wang N, Zhang L., Sex Transm Dis 34(8), 2007
PMID: 17277610
Prevalence of HIV and factors associated with risk behaviours among Chinese female sex workers in Hong Kong.
Lau JT, Ho SP, Yang X, Wong E, Tsui HY, Ho KM., AIDS Care 19(6), 2007
PMID: 17573591
Surplus men, sex work, and the spread of HIV in China.
Tucker JD, Henderson GE, Wang TF, Huang YY, Parish W, Pan SM, Chen XS, Cohen MS., AIDS 19(6), 2005
PMID: 15802971
High risk populations and HIV-1 infection in China.
Zhu TF, Wang CH, Lin P, He N., Cell Res. 15(11-12), 2005
PMID: 16354559
Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China.
Zhang Y, Lu L, Ba L, Liu L, Yang L, Jia M, Wang H, Fang Q, Shi Y, Yan W, Chang G, Zhang L, Ho DD, Chen Z., PLoS Med. 3(11), 2006
PMID: 17105339

AUTHOR UNKNOWN, 2000

Littell RC., 1996
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M., BMC Infect. Dis. 6(), 2006
PMID: 16762050
High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.
Zhang C, Yang R, Xia X, Qin S, Dai J, Zhang Z, Peng Z, Wei T, Liu H, Pu D, Luo J, Takebe Y, Ben K., J. Acquir. Immune Defic. Syndr. 29(2), 2002
PMID: 11832691
HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
Miller M, Mella I, Moi H, Eskild A., J. Acquir. Immune Defic. Syndr. 33(3), 2003
PMID: 12843749
The lack of selection bias in a snowball sampled case-control study on drug abuse.
Lopes CS, Rodrigues LC, Sichieri R., Int J Epidemiol 25(6), 1996
PMID: 9027534
Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.
Platt L, Wall M, Rhodes T, Judd A, Hickman M, Johnston LG, Renton A, Bobrova N, Sarang A., J Urban Health 83(6 Suppl), 2006
PMID: 17096189
Drugs and social exclusion in ten European cities.
March JC, Oviedo-Joekes E, Romero M., Eur Addict Res 12(1), 2006
PMID: 16352901
Modeling sources of self-report bias in a survey of drug use epidemiology.
Johnson T, Fendrich M., Ann Epidemiol 15(5), 2005
PMID: 15840552
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.
Abdul-Quader AS, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Sabin K, Gallagher K, Des Jarlais DC., J Urban Health 83(3), 2006
PMID: 16739048
Implementation and analysis of respondent driven sampling: lessons learned from the field.
Abdul-Quader AS, Heckathorn DD, Sabin K, Saidel T., J Urban Health 83(6 Suppl), 2006
PMID: 17058119
Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence.
Frost SD, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, Magis-Rodriguez C, Strathdee SA., J Urban Health 83(6 Suppl), 2006
PMID: 17072761

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 18680587
PubMed | Europe PMC

Suchen in

Google Scholar